Inventor · disambiguated record
Christine Bonzon
Also filed as: BONZON CHRISTINE
17 granted patents·15 pending applications·115 citations·filing 2010–2025
93Inventor score
Top patents by PatentIndex Score
32 records- 0198US10793632B2Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptorsXENCOR INC·Filed 2017·Granted Oct 6, 2020·22 cites·5 claims
- 0298US10550185B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragmentsXENCOR INC·Filed 2017·Granted Feb 4, 2020·29 cites·13 claims
- 0398US10501543B2IL15/IL15Rα heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2017·Granted Dec 10, 2019·13 cites·6 claims
- 0497US10787518B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2017·Granted Sep 29, 2020·15 cites·19 claims
- 0595US12509495B2LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domainsXENCOR INC·Filed 2023·Granted Dec 30, 2025·1 cites·5 claims
- 0695US11505595B2TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domainsXENCOR INC·Filed 2019·Granted Nov 22, 2022·9 cites·12 claims
- 0795US10981992B2Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptorsXENCOR INC·Filed 2018·Granted Apr 20, 2021·6 cites·6 claims
- 0894US12239688B2IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereofXENCOR INC·Filed 2021·Granted Mar 4, 2025·2 cites·20 claims
- 0993US11377477B2PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereofXENCOR INC·Filed 2019·Granted Jul 5, 2022·7 cites·13 claims
- 1091US11932675B2PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved propertiesGENENTECH INC·Filed 2020·Granted Mar 19, 2024·2 cites·15 claims
- 1191US11584794B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragmentsXENCOR INC·Filed 2019·Granted Feb 21, 2023·2 cites·9 claims
- 1290US11524991B2PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereofXENCOR INC·Filed 2019·Granted Dec 13, 2022·5 cites·17 claims
- 1385US2025333519A1Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
- 1484US11236170B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2019·Granted Feb 1, 2022·1 cites·5 claims
- 1583US2023220081A1BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTSXENCOR INC·Filed 2022·Application pending·0 cites
- 1683US2025057919A1Il-15/il-15ra heterodimeric fc fusion proteins and uses thereofXENCOR INC·Filed 2024·Application pending·0 cites
- 1781US2023041377A1Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2022·Application pending·0 cites
- 1880US2022195048A1IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINSXENCOR INC·Filed 2022·Application pending·0 cites
- 1979US11312770B2Bispecific and monospecific antibodies using novel anti-PD-1 sequencesXENCOR INC·Filed 2018·Granted Apr 26, 2022·1 cites·4 claims
- 2079US2024026002A1Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptorsXENCOR INC·Filed 2023·Application pending·0 cites
- 2177US2020040083A1IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINSXENCOR INC·Filed 2019·Application pending·0 cites
- 2273US11492407B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2019·Granted Nov 8, 2022·0 cites·6 claims
- 2373US2024294593A1Pd-1 targeted il-15/il-15ralpha fc fusion proteins with improved propertiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 2471US2023331813A1TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND TIM-3 ANTIGEN BINDING DOMAINSXENCOR INC·Filed 2022·Application pending·0 cites
- 2569US12152076B2Bispecific and monospecific antibodies using novel anti-PD-1 sequencesXENCOR INC·Filed 2022·Granted Nov 26, 2024·0 cites·11 claims
- 2669US2021253706A1Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptorsXENCOR INC·Filed 2021·Application pending·0 cites
- 2768US2023055445A1Pd-1 targeted il-15/il-15ralpha fc fusion proteins and uses in combination therapies thereofXENCOR INC·Filed 2022·Application pending·0 cites
- 2864US2019365861A1Il-15/il-15ra heterodimeric fc fusion proteins and uses thereofXENCOR INC·Filed 2019·Application pending·0 cites
- 2964US2019352362A1LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINSXENCOR INC·Filed 2019·Application pending·0 cites
- 3060US2021095030A1Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptorsXENCOR INC·Filed 2020·Application pending·0 cites
- 3157US11512122B2IL-7-FC-fusion proteinsXENCOR INC·Filed 2020·Granted Nov 29, 2022·0 cites·9 claims
- 3234US2011195111A1Aqueous compositions and methodsNATIVIS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine Bonzon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →